Showing 1 - 10 of 1,601
Litigated pharmaceutical patents are a valuable source of data on how much inventiveness is required for a patent grant and what are the costs of patents. Although innovation is central to economic growth and the competitiveness of firms, there are few data about either the cost of granted...
Persistent link: https://www.econbiz.de/10014122468
Planet earth is host to a dazzling variety of living organisms. This diversity of life, or – biodiversity, is vital to the survival and prosperity of humanity, supplying such vital amenities as food, clothing, shelter, natural biochemicals useful in medicine, industry, and agriculture, and...
Persistent link: https://www.econbiz.de/10014196348
The Hatch-Waxman Act was intended to encourage makers of generic drugs to seek early entry into drug markets controlled by patents, in part by challenging the patents before they expire. Some patentees have settled these challenges by agreeing to pay the challengers tens or hundreds of millions...
Persistent link: https://www.econbiz.de/10014061863
Despite their potential efficiency benefits, voluntary consensus standards have over the past decade become the subject of significant private litigation, regulatory enforcement and policy debate. Much of the controversy centers on the perceived proliferation of patents covering standardized...
Persistent link: https://www.econbiz.de/10014133939
In this paper we examine the importance of financial and other obstacles to innovation in the Netherlands using statistical information from the CIS 3.5 innovation survey. We report results on the effect of these obstacles on the firms' decision to abandon, prematurely stop, seriously slow down,...
Persistent link: https://www.econbiz.de/10010275869
A corporate governance model built around hierarchical structures, in which authority and empowerment flows through the board of directors to management and eventually staff, and the board is responsible to shareholders (the owners) of a company, worked well in an era of industrial capitalism,...
Persistent link: https://www.econbiz.de/10012989082
While the impact of M&A on R&D and innovation examined at the aggregate level left inconclusive evidence, we find that at the level of the R&D process both the technological and the market relatedness between the target and the acquirer are helpful dimensions to identify effects. Using...
Persistent link: https://www.econbiz.de/10014029730
This paper provides empirical evidence on the relationship between cross-border acquisitions and innovation activities of the acquirer. For the empirical analysis a unique firm-level data set is constructed that combines survey data for German firms with a merger and acquisition database. After...
Persistent link: https://www.econbiz.de/10011609709
In this paper we examine the importance of financial and other obstacles to innovation in the Netherlands using statistical information from the CIS 3.5 innovation survey. We report results on the effect of these obstacles on the firms' decision to abandon, prematurely stop, seriously slow down,...
Persistent link: https://www.econbiz.de/10013316602
Low-emission vehicle (LEV) technologies have grown in the 1990s, but have since experienced fluctuating interest. Initially, electric vehicles (EVs) were the most promising technology. Most large car firms developed EVs and started bringing them to the market, in limited numbers. Yet, car firms...
Persistent link: https://www.econbiz.de/10014036005